Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

Published on January 7, 2025

will also be available on www.covalon.com under Financials on the Investors tab. Financial Performance For the three-month period ended

Continue reading on website
Other news

Stoke Therapeutics Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome

January 7, 2025
Conference Call for Analysts and InvestorsStoke management will host a webcast and conference call for analysts and investors on Tuesday,

Bregal Sagemount Basecamp Announces Strategic Growth Investment in 360 Advanced

January 7, 2025
”), a leading growth-focused private equity firm, today announced a minority growth investment from its Basecamp fund, in 360 Advanced, a